Elucidating the exact pharmacological system of motion (MOA) of naturally transpiring compounds is usually difficult. Even though Tarselli et al. (60) developed the initial de novo synthetic pathway to conolidine and showcased this The natural way transpiring compound successfully suppresses responses to the two chemically induced and inflammation-